Application of heparinized cellulose affinity membranes in recombinant adeno-associated virus serotype 2 binding and delivery

Journal of Membrane Science

Volumn 310, Issue 1-2, 2008, Pages 141-148

  Wang, Zhi Hao ^a   Chien, Wei Che ^a   Yue, Tse Wei ^a   Tang, Shiue Cheng ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

AAV2; Affinity membrane chromatography; Cellulose; Gene transfer; Heparin

Indexed keywords

ADSORPTION; GENE TRANSFER; MASS TRANSFER;

AFFINITY MEMBRANE CHROMATOGRAPHY; VIRAL VECTOR DELIVERY;

CELLULOSE;

ADENOVIRUS VECTOR; CELLULOSE; HEPARAN SULFATE; HEPARIN; PROTEOHEPARAN SULFATE;

ADSORPTION; CELLULOSE; GENE TRANSFER; MASS TRANSFER;

ADENOVIRUS; ADSORPTION KINETICS; AFFINITY CHROMATOGRAPHY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CROSS LINKING; DRUG CONJUGATION; EMBRYO; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LIGAND BINDING; MEMBRANE BINDING; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE CULTURE; ULTRACENTRIFUGATION; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS RECOMBINANT;

ADSORPTION; CELLULOSE; MASS TRANSFER;

EID: 38649115332     PISSN: 03767388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.memsci.2007.10.048     Document Type: Article

References (31)

1. Kalbfuss B., Wolff M., Geisler L., Tappe A., Wickramasinghe R., Thom V., and Reichl U. Direct capture of influenza A virus from cell-culture supernatant with Sartobind anion-exchange membrane adsorbers. J. Membr. Sci. 299 (2007) 251-260
2. Duffy A.M., O'Doherty A.M., O'Brien T., and Strappe P.M. Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques. Gene Ther. 12 Suppl. 1 (2005) S62-S72
3. Specht R., Han B.B., Wickramasinghe S.R., Carlson J.O., Czermak P., Wolf A., and Reif O.W. Densonucleosis virus purification by ion exchange membranes. Biotechnol. Bioeng. 88 (2004) 465-473
4. Karger A., Bettin B., Granzow H., and Mettenleiter T.C. Simple and rapid purification of alphaherpesviruses by chromatography on a cation exchange membrane. J. Virol. Methods 70 (1998) 219-224
5. van Reis R., and Zydney A. Bioprocess membrane technology. J. Membr. Sci. 297 (2007) 16-50
6. Klein E. Affinity membranes: a 10-year review. J. Membr. Sci. 179 (2000) 1-27
7. Stachelek S.J., Song C., Alferiev I., Defelice S., Cui X., Connolly J.M., Bianco R.W., and Levy R.J. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther. 11 (2004) 15-24
8. Yue T.W., Chien W.C., Tseng S.J., and Tang S.C. EDC/NHS-mediated heparinization of small intestinal submucosa for recombinant adeno-associated virus serotype 2 binding and transduction. Biomaterials 28 (2007) 2350-2357
9. Dimitrova M., Arntz Y., Lavalle P., Meyer F., Wolf M., Schuster C., Haikel Y., Voegel J.C., and Ogier J. Adenoviral gene delivery from multilayered polyelectrolyte architectures. Adv. Funct. Mater. 17 (2007) 233-245
10. Phillips J.E., Gersbach C.A., and Garcia A.J. Virus-based gene therapy strategies for bone regeneration. Biomaterials 28 (2007) 211-229
11. Branski L.K., Pereira C.T., Herndon D.N., and Jeschke M.G. Gene therapy in wound healing: present status and future directions. Gene Ther. 14 (2007) 1-10
12. Manno C.S., Arruda V.R., Pierce G.F., Glader B., Ragni M., Rasko J., Ozelo M.C., Hoots K., Blatt P., Konkle B., Dake M., Kaye R., Razavi M., Zajko A., Zehnder J., Nakai H., Chew A., Leonard D., Wright J.F., Lessard R.R., Sommer J.M., Tigges M., Sabatino D., Luk A., Jiang H., Mingozzi F., Couto L., Ertl H.C., High K.A., and Kay M.A. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12 (2006) 342-347
13. Moss R.B., Rodman D., Spencer L.T., Aitken M.L., Zeitlin P.L., Waltz D., Milla C., Brody A.S., Clancy J.P., Ramsey B., Hamblett N., and Heald A.E. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest 125 (2004) 509-521
14. Summerford C., and Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72 (1998) 1438-1445
15. Auricchio A., Hildinger M., O'Connor E., Gao G.P., and Wilson J.M. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12 (2001) 71-76
16. Miyamoto T., Takahashi S., Ito H., Inagaki H., and Noishiki Y. Tissue biocompatibility of cellulose and its derivatives. J. Biomed. Mater. Res. 23 (1989) 125-133
17. Martson M., Viljanto J., Hurme T., and Saukko P. Biocompatibility of cellulose sponge with bone. Eur. Surg. Res. 30 (1998) 426-432
18. Tate M.C., Shear D.A., Hoffman S.W., Stein D.G., and LaPlaca M.C. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 22 (2001) 1113-1123
19. Fricain J.C., Granja P.L., Barbosa M.A., de Jeso B., Barthe N., and Baquey C. Cellulose phosphates as biomaterials. In vivo biocompatibility studies. Biomaterials 23 (2002) 971-980
20. Martson M., Viljanto J., Laippala P., and Saukko P. Connective tissue formation in subcutaneous cellulose sponge implants in the rat. The effect of the size and cellulose content of the implant. Eur. Surg. Res. 30 (1998) 419-425
21. Salata L.A., Hatton P.V., Devlin A.J., Craig G.T., and Brook I.M. In vitro and in vivo evaluation of e-PTFE and alkali-cellulose membranes for guided bone regeneration. Clin. Oral Implan. Res. 12 (2001) 62-68
22. Muller F.A., Muller L., Hofmann I., Greil P., Wenzel M.M., and Staudenmaier R. Cellulose-based scaffold materials for cartilage tissue engineering. Biomaterials 27 (2006) 3955-3963
23. Entcheva E., Bien H., Yin L., Chung C.Y., Farrell M., and Kostov Y. Functional cardiac cell constructs on cellulose-based scaffolding. Biomaterials 25 (2004) 5753-5762
24. Berridge M.V., and Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303 (1993) 474-482
25. Tang S.C., and Sambanis A. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochem. Biophys. Res. Commun. 303 (2003) 645-652
26. Tang S.C., and Sambanis A. Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. J. Gene Med. 6 (2004) 1003-1013
27. Wickramasinghe S.R., Carlson J.O., Teske C., Hubbuch J., and Ulbricht M. Characterizing solute binding to macroporous ion exchange membrane adsorbers using confocal laser scanning microscopy. J. Membr. Sci. 281 (2006) 609-618
28. Burova E., and Ioffe E. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther. 12 Suppl. 1 (2005) S5-S17
29. Blouin V., Brument N., Toublanc E., Raimbaud I., Moullier P., and Salvetti A. Improving rAAV production and purification: towards the definition of a scaleable process. J. Gene Med. 6 Suppl. 1 (2004) S223-S228
30. Brument N., Morenweiser R., Blouin V., Toublanc E., Raimbaud I., Cherel Y., Folliot S., Gaden F., Boulanger P., Kroner-Lux G., Moullier P., Rolling F., and Salvetti A. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol. Ther. 6 (2002) 678-686
31. Tamayose K., Hirai T., and Shimada T. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7 (1996) 507-513